# A Randomized,Open,Controlled Clinical Study to Evaluate the Efficacy of ASC09F and Ritonavir for 2019-nCoV Pneumonia

> **NCT04261270** · PHASE3 · UNKNOWN · sponsor: **Tongji Hospital** · enrollment: 60 (estimated)

## Conditions studied

- 2019-nCoV Pneumonia

## Interventions

- **DRUG:** ASC09F+Oseltamivir
- **DRUG:** Ritonavir+Oseltamivir
- **DRUG:** Oseltamivir

## Key facts

- **NCT ID:** NCT04261270
- **Lead sponsor:** Tongji Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-02-01
- **Primary completion:** 2020-05-01
- **Final completion:** 2020-07-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2020-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04261270

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04261270, "A Randomized,Open,Controlled Clinical Study to Evaluate the Efficacy of ASC09F and Ritonavir for 2019-nCoV Pneumonia". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04261270. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*